Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Prothena Corp Public's revenue for the twelve months ending Jun 30, 2026 was $54.53M, up 427.3% year over year. For fiscal 2025 it was $9.68M, down 92.8% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $200.58M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.68M | -92.8% |
| FY2024 | Dec 31, 2024 | $135.16M | +47.9% |
| FY2023 | Dec 31, 2023 | $91.37M | +69.5% |
| FY2022 | Dec 31, 2022 | $53.91M | -73.1% |
| FY2021 | Dec 31, 2021 | $200.58M | +23414.3% |
| FY2020 | Dec 31, 2020 | $853.00K | +4.8% |
| FY2019 | Dec 31, 2019 | $814.00K | -14.8% |
| FY2018 | Dec 31, 2018 | $955.00K | -96.5% |
| FY2017 | Dec 31, 2017 | $27.52M | +2508.4% |
| FY2016 | Dec 31, 2016 | $1.06M | -34.3% |
| FY2015 | Dec 31, 2015 | $1.61M | -96.8% |
| FY2014 | Dec 31, 2014 | $50.85M | +7422.8% |
| FY2013 | Dec 31, 2013 | $676.00K | -74.6% |
| FY2012 | Dec 31, 2012 | $2.66M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.01M | -77.1% |
| Q1 FY2026 | Mar 31, 2026 | $51.08M | +1706.4% |
| Q4 FY2025 | Dec 31, 2025 | $21.00K | -99.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.42M | +149.0% |
| Q2 FY2025 | Jun 30, 2025 | $4.42M | -96.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.83M | +5556.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.12M | +571.8% |
| Q3 FY2024 | Sep 30, 2024 | $970.00K | -98.9% |
| Q2 FY2024 | Jun 30, 2024 | $132.01M | +3184.7% |
| Q1 FY2024 | Mar 31, 2024 | $50.00K | -97.7% |
| Q4 FY2023 | Dec 31, 2023 | $316.00K | -99.4% |
| Q3 FY2023 | Sep 30, 2023 | $84.87M | +5494.3% |
| Q2 FY2023 | Jun 30, 2023 | $4.02M | +206.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.17M | +88.1% |
| Q4 FY2022 | Dec 31, 2022 | $49.92M | +4159.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.52M | -98.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.31M | -97.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.15M | +620.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.17M | +225.6% |
| Q3 FY2021 | Sep 30, 2021 | $139.17M | +88545.9% |
| Q2 FY2021 | Jun 30, 2021 | $60.07M | +30705.6% |
| Q1 FY2021 | Mar 31, 2021 | $160.00K | +13.5% |
| Q4 FY2020 | Dec 31, 2020 | $360.00K | +40.6% |
| Q3 FY2020 | Sep 30, 2020 | $157.00K | -23.4% |
| Q2 FY2020 | Jun 30, 2020 | $195.00K | +16.8% |
| Q1 FY2020 | Mar 31, 2020 | $141.00K | -24.2% |
| Q4 FY2019 | Dec 31, 2019 | $256.00K | +32.0% |
| Q3 FY2019 | Sep 30, 2019 | $205.00K | -19.6% |
| Q2 FY2019 | Jun 30, 2019 | $167.00K | -40.1% |
| Q1 FY2019 | Mar 31, 2019 | $186.00K | -18.1% |
| Q4 FY2018 | Dec 31, 2018 | $194.00K | -15.3% |
| Q3 FY2018 | Sep 30, 2018 | $255.00K | +16.4% |
| Q2 FY2018 | Jun 30, 2018 | $279.00K | -99.0% |
| Q1 FY2018 | Mar 31, 2018 | $227.00K | -12.4% |
| Q4 FY2017 | Dec 31, 2017 | $229.00K | +33.9% |
| Q3 FY2017 | Sep 30, 2017 | $219.00K | -23.4% |
| Q2 FY2017 | Jun 30, 2017 | $26.81M | – |
| Q1 FY2017 | Mar 31, 2017 | $259.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $171.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $286.00K | – |
See a number that looks wrong?